期刊文献+

血清超敏C反应蛋白和同型半胱氨酸检测在冠心病中的应用 被引量:5

原文传递
导出
摘要 目的探讨血清超敏C反应蛋白(hs-CRP)和同型半胱氨酸(Hcy)的检测在冠心病中的应用价值。方法对58例冠心病患者和50例健康体检者进行血清hs-CRP和Hcy的检测并进行比较。结果冠心病患者下述指标水平明显高于健康体检者:血清hs-CRP〔(8.32±3.76)vs(3.12±1.56)mg/L〕和Hcy〔(20.45±8.92)vs(6.56±3.43)μmol/L〕(P均<0.01)。结论血清高hs-CRP和高Hcy水平与冠心病的发生、发展有密切关系,其检测对冠心病的预防、诊断及治疗有重要的临床意义。
出处 《中国临床研究》 CAS 2011年第8期721-721,共1页 Chinese Journal of Clinical Research
  • 相关文献

参考文献5

二级参考文献21

  • 1张卫茹,侯凡凡,刘尚喜,郭志坚,周展眉,王国保,富宁,刘志强,王力,周玫.晚期糖基化终产物通过氧化应激加速动脉粥样硬化斑块形成[J].中华医学杂志,2004,84(13):1066-1070. 被引量:28
  • 2李保华,陶云海,王克义,牛国忠.脑梗死患者血浆同型半胱氨酸检测的临床意义[J].浙江临床医学,2006,8(1):17-18. 被引量:22
  • 3高炜,中华医学杂志,1999年,79卷,15页
  • 4Lentz SR. Mechanisms of thrombosis in hyperhomocysteinemia[J]. Curr Opin Hematol, 1998, 5 (5) :343- 349.
  • 5Selhub J, JacquesPF, Boston AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis [ J ]. N Engl J Med, 1995,332 ( 5 ) : 286-995.
  • 6Boysen G, Brander T, Christensen H, et al. Homocysteine and risk of recurrent stroke [ J ]. Stroke, 2003, 34(5) :1258-1261.
  • 7Martinelli I, Battaglioli T, Pedotti P, et al. Hyperhomocysteine in cerebral vein thrombosis [ J]. Blood, 2003, 102(4) :1363-1366.
  • 8FOLEY RN, PARFREY PS, SARNAK MJ. Epidemiology of cardiovascular disease in chronic renal disease [J]. J Am Soc Nephrol, 1998, 9(12): S16-23.
  • 9AU-YEUNG KK, WOO CW, SUNG FL, et al. Hyperhomocysteinemia activates nuclear factor-kappaB in endothelial cells via oxidative stress[J]. Circ Res, 2004, 94(1): 28-36.
  • 10MAKITA Z, VLASSARA H, CERAMI A, et al. Immunochemical detection of advanced glycosylation end products in vivo [J]. J Biol Chem, 1992, 267(8): 5133-5138.

共引文献117

同被引文献52

  • 1Hansson GK. Inflammation, atherrosclerosis,and coronary artery dis- ease[ J]. N Engl J Med,2005,352(16) : 1685 - 1695.
  • 2Coombs BD, Rapp JH, Uresell PC, et al. Structure of plaque at carot- id bifurcation:high-resolution on MRI with histological correlation [ J]. Stroke,2001,32( 1 1 ) :2516 - 2521.
  • 3Wilson AM, Ryan MC, Boyle AJ. The novel role of C-reactive protein in cardiovascular disease:risk marker or pathogen [ J ]. Int J Cardiol, 2006,106(3) :291 -297.
  • 4Lindmark E, Diderholm E, Wallentin L, et al. Relationship between interleukin-6 and mortality in patients with unstable coronary artery diease: effects of early invasive or noninvasive strategy [ J ]. JAMA, 2001,286(17) :2107 -2113.
  • 5Garcia-Calvo M, Lisnock J, Bull HG, et al. The target of ezetimibe is Niemann-Pick C1-Likel ( NPC1L1 ) [ J]. Proc Natl Acad Sci USA, 2005,102(23) :8132-8137.
  • 6Sudhop T, Ltitjohann D, Kodal A, et al. Inhibition of intestinal cho- lesterol absorption by ezetimibe in humans [ J ]. Circulation, 2002, 106( 15 ) :1943 - 1948.
  • 7Davidson MH, Ballantyne CM, Kerzner B, et al. Efficacy and safty of ezetimibe coadrministered with statins : radomnized, placebo-con- trolled,blinded experience in 2 382 patients with primary hyper cholestemlemia[ J ]. Int. J Clin Pratt,2004,58 (8) :746 - 755.
  • 8Famier M, Freeman MW, Macdonell G, et al. Efficacy and safety of the coadrministered of ezetimibe with fenofibrate in patients with mixed hyperlipidaemia [J]. Eur Heart J,2005,26 ( 9 ) : 897 - 905.
  • 9林志芳,岑丽莲,柯尊彬,贾冰,李海珠,帅虎,梅敏.冠心病患者血清同型半胱氨酸、超敏C反应蛋白、脂蛋白(a)和D-二聚体的水平变化分析[J].热带医学杂志,2008,8(7):704-705. 被引量:9
  • 10金鹏,苏红波,李琳.同型半胱氨酸与C反应蛋白对冠心病的临床价值[J].中华实用诊断与治疗杂志,2009,23(2):181-182. 被引量:29

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部